Health Canada drug identification number

DIN 00738840 — NOVO-HYDROXYZIN 50 MG

NOVO-HYDROXYZIN is a capsule of Hydroxyzine marketed by TEVA CANADA LIMITED. The full Hydroxyzine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
00738840
Brand name
NOVO-HYDROXYZIN
Active ingredient
Hydroxyzine
Strength
50 MG
Dosage form
CAPSULE
Route
ORAL
Manufacturer
TEVA CANADA LIMITED
Health Canada status
DORMANT
Drug class
Antihistamine (anxiolytic / antipruritic)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Hydroxyzine products

DINBrandStrengthFormManufacturerStatus
00024694 ATARAX 10 MG SYRUP SEARCHLIGHT PHARMA INC MARKETED
00646059 HYDROXYZINE 10 MG CAPSULE AA PHARMA INC MARKETED
00646024 HYDROXYZINE 25 MG CAPSULE AA PHARMA INC MARKETED
00646016 HYDROXYZINE 50 MG CAPSULE AA PHARMA INC MARKETED
00742813 HYDROXYZINE HYDROCHLORIDE INJECTION USP 50 MG LIQUID SANDOZ CANADA INCORPORATED MARKETED
02231209 HYDROXYZINE HYDROCHLORIDE INJECTION, USP 50 MG SOLUTION STERIMAX INC DORMANT
00738824 NOVO-HYDROXYZIN 10 MG CAPSULE TEVA CANADA LIMITED DORMANT
00738832 NOVO-HYDROXYZIN 25 MG CAPSULE TEVA CANADA LIMITED DORMANT

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.